- 2010 Educational
Grant Application - CALDA Survey Results
- Published Articles
- Other Articles
- Testimony and
Presentations - Posters
Testimony and Presentations
Harris, SJ, Johnson L, Mervine P, Stricker, RS.
Testimony for California Senate Health and Human Services Committee Hearing on “Lyme Disease: Issues in Diagnosis and Reporting,”
February 25, 2004.
Johnson L, Harris N.
Pennsylvania: Testimony before the Pennsylvania legislative health committee and group of insurers regarding insurance and Lyme disease (in collaboration with Pat Smith and Drs. Cameron, Smith, and Liegner),
March 18, 2005.
Johnson L, Stricker RB, Harris SJ.
California: Testimony before California Medical Board regarding two standards of care,
February 18, 2005.
Johnson L, Feldman B., Feldman, S.
Los Angeles County Board of Supervisors: Presentation of Lyme disease issues in Los Angeles.
October 17, 2005.
Johnson L.
“Ethics in health care communications and the role of informed consent.”
Presentation to
Canadian Consensus Conference at invitation of Canadian government (collaboration with Drs. Harris, Donta, and Cameron), March 8-9, 2006.
Johnson L.
“Specialty Bias, Guidelines, Clinical Judgment, and Quality of Healthcare.”
Meeting with CDC Director Julie Gerberding and staff regarding Lyme disease testing and treatment issues (in collaboration with Drs. Fallon, Schutzer and Pat Smith), July 12, 2006.
Johnson L.
Presentation of “The Treatment of Lyme Disease: A medicolegal assessment.”
ILADS Annual Scientific Conference.Rye, NY, October 24, 2004.
Mervine P.
“Direct Lab Reporting of Lyme Disease,”
Written testimony to Connecticut legislators supporting Bill 5747, February 2007.
Mervine P.
“Lab Reporting of Lyme Disease – How is it Working?”
Testimony to CDPH Lyme Disease Advisory Committee, March 2006.
Mervine P.
“Need for LDAC Reform.”
Testimony to CDPH Lyme Disease Advisory Committee, November 14, 2002.
Mervine P.
Outline of presentation at meeting with NIH Health and Human Services,
November 5, 2003, along with Pat Smith and other Lyme community patient advocates and medical experts.
Mervine P.
“Summary of Accomplishments (or Lack Thereof) of NIH Advisory Committee for the Lyme Disease Clinical Trials.”
Letter to NIH, May 26, 2002.
